GB2500092B - Syringe - Google Patents

Syringe

Info

Publication number
GB2500092B
GB2500092B GB201301368A GB201301368A GB2500092B GB 2500092 B GB2500092 B GB 2500092B GB 201301368 A GB201301368 A GB 201301368A GB 201301368 A GB201301368 A GB 201301368A GB 2500092 B GB2500092 B GB 2500092B
Authority
GB
United Kingdom
Prior art keywords
syringe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
GB201301368A
Other versions
GB201301368D0 (en
GB2500092A (en
Inventor
Juergen Sigg
Chistophe Royer
Andrew Mark Bryant
Heinrich Martin Buettgen
Marie Picci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47790686&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GB2500092(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from AU2012101677A external-priority patent/AU2012101677B4/en
Priority claimed from DE201320000688 external-priority patent/DE202013000688U1/en
Application filed by Novartis AG filed Critical Novartis AG
Publication of GB201301368D0 publication Critical patent/GB201301368D0/en
Publication of GB2500092A publication Critical patent/GB2500092A/en
Application granted granted Critical
Publication of GB2500092B publication Critical patent/GB2500092B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31511—Piston or piston-rod constructions, e.g. connection of piston with piston-rod
    • A61M5/31513—Piston constructions to improve sealing or sliding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/206—Ethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/16—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor using chemical substances
    • A61L2/20—Gaseous substances, e.g. vapours
    • A61L2/208—Hydrogen peroxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2202/00—Aspects relating to methods or apparatus for disinfecting or sterilising materials or objects
    • A61L2202/20—Targets to be treated
    • A61L2202/24—Medical instruments, e.g. endoscopes, catheters, sharps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M2005/3103—Leak prevention means for distal end of syringes, i.e. syringe end for mounting a needle
    • A61M2005/3104—Caps for syringes without needle
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A61M5/3137—Specially designed finger grip means, e.g. for easy manipulation of the syringe rod
    • A61M2005/3139—Finger grips not integrally formed with the syringe barrel, e.g. using adapter with finger grips
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M2005/31508—Means for blocking or restricting the movement of the rod or piston provided on the piston-rod
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/3129—Syringe barrels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178—Syringes
    • A61M5/31—Details
    • A61M5/315—Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31501—Means for blocking or restricting the movement of the rod or piston
    • A61M5/31505—Integral with the syringe barrel, i.e. connected to the barrel so as to make up a single complete piece or unit
GB201301368A 2012-07-03 2013-01-25 Syringe Active GB2500092B (en)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
EP12174860 2012-07-03
EP12189649 2012-10-23
AU2012101677A AU2012101677B4 (en) 2012-07-03 2012-11-16 Device
AU2012101678A AU2012101678B4 (en) 2012-07-03 2012-11-16 Use of device
DE202012011016U DE202012011016U1 (en) 2012-07-03 2012-11-16 Aflibercept syringe
DE202012011260U DE202012011260U1 (en) 2012-07-03 2012-11-23 Ranibizumab Injection
DE202012011259U DE202012011259U1 (en) 2012-07-03 2012-11-23 Bevacizumab syringe
EP12195360 2012-12-03
DE201320000688 DE202013000688U1 (en) 2012-07-03 2013-01-23 Glass syringe
AU2013100070A AU2013100070B4 (en) 2012-07-03 2013-01-23 Use of device
AU2013100071A AU2013100071C4 (en) 2012-07-03 2013-01-23 Device

Publications (3)

Publication Number Publication Date
GB201301368D0 GB201301368D0 (en) 2013-03-13
GB2500092A GB2500092A (en) 2013-09-11
GB2500092B true GB2500092B (en) 2014-02-12

Family

ID=47790686

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201301368A Active GB2500092B (en) 2012-07-03 2013-01-25 Syringe

Country Status (2)

Country Link
AU (5) AU2013100071C4 (en)
GB (1) GB2500092B (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10780228B2 (en) 2012-05-07 2020-09-22 Medline Industries, Inc. Prefilled container systems
JOP20200175A1 (en) 2012-07-03 2017-06-16 Novartis Ag Syringe
EP3492495A1 (en) * 2014-05-12 2019-06-05 Formycon AG Pre-filled plastic syringe containing a vegf antagonist
RU2751510C2 (en) 2015-11-18 2021-07-14 Сио2 Медикал Продактс, Инк. Pharmaceutical packaging for ophthalmic formulations
EP3377100A1 (en) * 2015-11-18 2018-09-26 Formycon AG Pre-filled pharmaceutical package comprising a liquid formulation of a vegf-antagonist
US20170349313A1 (en) 2016-06-01 2017-12-07 Centurion Medical Products Corporation Methods for manufacturing non-glass prefilled syringes
WO2018217995A1 (en) * 2017-05-24 2018-11-29 Formycon Ag Sterilizable pre-filled pharmaceutical packages comprising a liquid formulation of a vegf-antagonist
CN116490233A (en) * 2020-12-01 2023-07-25 勃林格殷格翰国际公司 Administration device, in particular for intraocular liquid administration
WO2024049793A1 (en) * 2022-08-30 2024-03-07 Amgen Inc. System and method of limiting subvisible particles in a syringe

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047325A1 (en) * 2004-10-21 2006-05-04 Genentech, Inc. Method for treating intraocular neovascular diseases
US20060172944A1 (en) * 2005-02-02 2006-08-03 Wiegand Stanley J Method of treating eye injury with local administration of a VEGF inhibitor
WO2006128564A1 (en) * 2005-05-31 2006-12-07 Baxter International Inc. Polypropylene hollow barrel with sliding coated rubber piston
WO2007035621A1 (en) * 2005-09-16 2007-03-29 (Osi) Eyetech, Inc. Ophthalmic syringe
WO2007084765A2 (en) * 2006-01-19 2007-07-26 Potentia Pharmaceuticals, Inc. Injectable combination therapy for eye disorders
WO2007149334A2 (en) * 2006-06-16 2007-12-27 Regeneron Pharmaceuticals, Inc. Vegf antagonist formulations suitable for intravitreal administration
CN201578690U (en) * 2010-01-21 2010-09-15 王建友 Syringe
US20120078224A1 (en) * 2010-03-31 2012-03-29 Ocuject, Llc Device and method for intraocular drug delivery
US20130012918A1 (en) * 2011-07-07 2013-01-10 Gary Foster Steady grip ophthalmic surgical syringe and method

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6243938B1 (en) * 1998-03-17 2001-06-12 Becton, Dickinson And Company Low silicone plastic prefillable syringe
PL371929A1 (en) * 2001-11-09 2005-07-11 Eyetech Pharmaceuticals Methods for treating ocular neovascular diseases
US20050043220A1 (en) * 2002-11-08 2005-02-24 Guyer David R. Methods and compositions for treating macular degeneration
ES2388138T3 (en) * 2003-08-27 2012-10-09 Ophthotech Corporation Combination therapy for the treatment of ocular neovascular disorders
US20080027113A1 (en) * 2003-09-23 2008-01-31 Zeldis Jerome B Methods of Using and Compositions Comprising Immunomodulatory Compounds for Treatment and Management of Macular Degeneration
US20060182783A1 (en) * 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
US20070071756A1 (en) * 2005-09-26 2007-03-29 Peyman Gholam A Delivery of an agent to ameliorate inflammation
AU2012202859B2 (en) * 2006-06-16 2014-12-04 Regeneron Pharmaceuticals, Inc. VEGF antagonist formulations suitable for intravitreal administration
US20080070855A1 (en) * 2006-09-20 2008-03-20 James Pitzer Gills Treatment with anti-VEGF agents to prevent postoperative inflammation and angiogenesis in normal and diseased eyes
WO2009020119A1 (en) * 2007-08-06 2009-02-12 Senju Pharmaceutical Co., Ltd. Pharmaceutical containing hif-1 alpha and hif-2 alpha expression inhibitor
EP2358746B1 (en) * 2008-11-03 2020-09-16 Molecular Partners AG Binding proteins inhibiting the vegf-a receptor interaction
AU2009323307B2 (en) * 2008-12-03 2015-02-19 Denki Kagaku Kogyo Kabushiki Kaisha Syringe
CA2760687A1 (en) * 2009-05-01 2010-11-04 Ophthotech Corporation Methods for treating or preventing ophthalmological diseases
KR20140014405A (en) * 2009-05-28 2014-02-06 글락소 그룹 리미티드 Combination of a tnf-alpha antagonist and a vegf antagonist for use in the treatment or prevention of diseases of the eye
CN102711756A (en) * 2010-01-14 2012-10-03 株式会社三和化学研究所 Pharmaceutical for preventing or treating disorders accompanied by ocular angiogenesis and/or elevated ocular vascular permeability

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006047325A1 (en) * 2004-10-21 2006-05-04 Genentech, Inc. Method for treating intraocular neovascular diseases
US20060172944A1 (en) * 2005-02-02 2006-08-03 Wiegand Stanley J Method of treating eye injury with local administration of a VEGF inhibitor
WO2006128564A1 (en) * 2005-05-31 2006-12-07 Baxter International Inc. Polypropylene hollow barrel with sliding coated rubber piston
WO2007035621A1 (en) * 2005-09-16 2007-03-29 (Osi) Eyetech, Inc. Ophthalmic syringe
WO2007084765A2 (en) * 2006-01-19 2007-07-26 Potentia Pharmaceuticals, Inc. Injectable combination therapy for eye disorders
WO2007149334A2 (en) * 2006-06-16 2007-12-27 Regeneron Pharmaceuticals, Inc. Vegf antagonist formulations suitable for intravitreal administration
CN201578690U (en) * 2010-01-21 2010-09-15 王建友 Syringe
US20120078224A1 (en) * 2010-03-31 2012-03-29 Ocuject, Llc Device and method for intraocular drug delivery
US20130012918A1 (en) * 2011-07-07 2013-01-10 Gary Foster Steady grip ophthalmic surgical syringe and method

Also Published As

Publication number Publication date
AU2013100145A4 (en) 2013-03-28
AU2013100146A4 (en) 2013-03-28
AU2013100070B4 (en) 2013-04-04
AU2013100070A4 (en) 2013-03-07
AU2013100071B4 (en) 2013-03-28
GB201301368D0 (en) 2013-03-13
AU2013100147A4 (en) 2013-03-28
AU2013100147B4 (en) 2013-04-18
AU2013100145B4 (en) 2013-05-02
AU2013100146B4 (en) 2013-04-18
AU2013100071C4 (en) 2013-05-02
GB2500092A (en) 2013-09-11
AU2013100071A4 (en) 2013-03-07

Similar Documents

Publication Publication Date Title
IL272915B (en) Syringe
HK1202816A1 (en) Syringe
EP2832391A4 (en) Syringe
GB2500092B (en) Syringe
HK1251496A1 (en) Syringe
EP2913076A4 (en) Syringe
EP2885023A4 (en) Syringe
PT3656373T (en) Syringe
TWM433204U (en) Syringe

Legal Events

Date Code Title Description
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1188404

Country of ref document: HK

REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1188404

Country of ref document: HK

S72Z Claim or counterclaim for revocation before the court (sect. 72 patents act1977)

Free format text: CLAIM LODGED; CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 23 MARCH 2022 (HP-2022-000008)

S72Z Claim or counterclaim for revocation before the court (sect. 72 patents act1977)

Free format text: CLAIM LODGED; CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 7 JUNE 2022 (HP-2022-000015)

S72Z Claim or counterclaim for revocation before the court (sect. 72 patents act1977)

Free format text: CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 23 MARCH 2022 (HP-2022-000008) AND 7 JUNE 2022 (HP-2022-000015). PATENT REVOKED BY THE CONSENT ORDER OF HIGH COURT DATED 10 AUGUST 2023.

S75Z Amendment of patent in infringement or revocation proceedings before the court (sect. 75/patents act 1977)

Free format text: APPLICATION DISMISSED; CLAIM FOR REVOCATION LODGED AT THE PATENTS COURT ON 23 MARCH 2022 (HP-2022-000008) AND 7 JUNE 2022 (HP-2022-000015). IN A CONSENT ORDER OF THE HIGH COURT DATED 10 AUGUST 2023, THE PATENT WAS REVOKED AND THE AMENDMENTS UNDER SECTION 75 FILED ON 3 MAY 2023 WERE DISMISSED.